Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM133A Inhibitors

Inhibitors of FAM133A function through various mechanisms to downregulate its activity, often by interfering with signaling pathways that either regulate its stability or activity. For instance, some inhibitors target the mTORC1 pathway, a crucial regulator of protein synthesis and cell growth, which can indirectly impact the stability of FAM133A by altering cellular growth signals. Similarly, broad-spectrum kinase inhibitors that suppress the phosphorylation state of numerous proteins could potentially affect FAM133A if its function is contingent on phosphorylation status. By inhibiting kinases within the PI3K/AKT pathway, which is intimately connected to cellular proliferation and survival, or the MAPK/ERK and p38 MAPK pathways, which are central to cell differentiation and stress responses, these inhibitors would indirectly decrease the stability or activity of FAM133A. Furthermore, inhibitors that prevent the action of JNK could alter the function of FAM133A if it is associated with apoptotic processes. Additionally, inhibitors that interfere with intracellular trafficking can indirectly impede the function of FAM133A. For instance, by inhibiting ADP-ribosylation factor, a compound would disrupt protein transport within the cell, which could be critical to the proper localization and function of FAM133A. Similarly, compounds that inhibit calcineurin could interfere with FAM133A activity by modulating T-cell signaling pathways, assuming FAM133A has a role in immune response mechanisms. Inhibition of MEK1 and MEK2 would likely disrupt the ERK pathway, potentially affecting FAM133A if it operates within this signaling cascade. Additionally, PKC inhibitors that suppress the PKC-mediated pathways could lead to the functional inhibition of FAM133A if it is regulated by such pathways. Lastly, selective inhibition of the Gs alpha subunit can reduce cAMP levels, which might also lead to the inhibition of FAM133A if cAMP-dependent pathways regulate its activity.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

A mTOR inhibitor that binds to FKBP12 and the resulting complex inhibits the mTORC1 pathway, which can downregulate protein synthesis and cell growth, indirectly leading to the inhibition of FAM133A, whose stability may be modulated by such cellular growth signals.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can inhibit a broad range of kinases involved in cell signaling, potentially reducing the phosphorylation state of proteins and thereby indirectly inhibiting FAM133A if it is subject to regulation by phosphorylation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that prevents phosphorylation of PI3K substrates, hindering the PI3K/AKT pathway. As the PI3K/AKT pathway is involved in cell survival and growth, its inhibition might indirectly decrease the stability or activity of FAM133A.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A PI3K inhibitor that leads to potential indirect inhibition of FAM133A through the disruption of the PI3K/AKT signaling pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An MEK inhibitor that disrupts the MAPK/ERK pathway, which is involved in cell proliferation and differentiation. Inhibition of this pathway could indirectly affect the function of FAM133A in case it's implicated in these cellular processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

An inhibitor of p38 MAPK, reducing the activity of this kinase involved in stress responses. The inhibition of p38 MAPK could indirectly influence the function of FAM133A if it is involved in stress response signaling pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor, preventing the activity of c-Jun N-terminal kinases which are important in apoptotic processes. If FAM133A is involved in pathways related to apoptosis, inhibition of JNK could indirectly affect its function.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

An inhibitor of ADP-ribosylation factor (Arf), leading to the disruption of protein transport within the cell. If FAM133A is involved in intracellular trafficking, Brefeldin A could indirectly inhibit its proper localization and function.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Inhibits calcineurin, thus affecting T-cell activation. If FAM133A plays a role in immune cell signaling, its function could be indirectly inhibited by Cyclosporin A's action on calcineurin.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of both MEK1 and MEK2, which could disrupt the ERK pathway. Such disruption could indirectly influence FAM133A function if the protein is involved in the signaling or regulatory processes modulated by the ERK pathway.